Oncologic safety of prophylactic nipple-sparing mastectomy: Outcomes of 1,255 cases exceeding a 6-year median follow-up [0.03%]
预防性保留乳头乳腺切除术的肿瘤安全性：中位随访超过6年的1255例结果分析
Thomas Amburn,Fatemeh P Parvin-Nejad,Varadan Sevilimedu et al.
Thomas Amburn et al.
Background: Prophylactic nipple-sparing mastectomy (PNSM) is performed to prevent the development of breast cancer. Despite the increasing usage of PNSM, large-cohort, long-term follow-up data is lacking. We aim to review...
Association of low muscle mass and obesity with mortality and cardiovascular outcomes in breast cancer: a population-based study [0.03%]
肌少症和肥胖与乳腺癌患者死亡率及心血管结局的关系：基于人口的队列研究
Sohyun Chun,Han Rim Lee,Jin-Hyung Jung et al.
Sohyun Chun et al.
Purpose: Obesity and low muscle mass (LMM) have been associated with adverse outcomes in cancer population. However, their individual and combined effects on long-term mortality and cardiovascular disease (CVD) outcomes i...
Fertility preservation in breast cancer patients: a systematic review and summary of current evidence and recommendations [0.03%]
乳腺癌患者的生育力保存：当前证据和建议的系统性回顾总结
Yaxin Chen,Ruirui Wang,Lei Wu et al.
Yaxin Chen et al.
Background: With the rising survival rates of breast cancer, fertility preservation has become a paramount concern for young patients throughout their anticancer treatment. We conducted a systematic review to assess and s...
A nomogram for predicting in-breast tumor recurrence risk in breast cancer patients treated with partial breast irradiation using intraoperative electron radiation therapy [0.03%]
用于预测接受术中电子放射治疗部分乳腺照射的乳腺癌患者同侧乳腺肿瘤复发风险的人表图
Damaris Patricia Rojas,Samuele Frassoni,Patrick Maisonneuve et al.
Damaris Patricia Rojas et al.
Purpose: The study aims to develop and validate a predictive tool for assessing the risk of in-breast tumor recurrence (IBTR) in breast cancer patients considered candidates for intraoperative radiotherapy using electrons...
Risk of myocardial infarction and stroke after breast cancer: an analysis of a population of 1.3 million women from North-West Italy [0.03%]
意大利西北部130万女性乳腺癌患者的心肌梗死和卒中风险分析
Fulvio Ricceri,Enrica Favaro,Alberto Catalano et al.
Fulvio Ricceri et al.
Purpose: Breast cancer (BC) is a leading public-health issue affecting women on a global scale. Thanks to the widespread implementation of screening programs and the improvement in therapies, women with BC live longer but...
Breast cancer risk level and prediction of tumor aggressiveness in the Athena Breast Health Network [0.03%]
阿特赫娜乳腺健康网络中的乳腺癌风险分层和预测肿瘤侵袭性研究
Katherine Leggat-Barr,Tomiyuri Lewis,Jeffrey A Tice et al.
Katherine Leggat-Barr et al.
Purpose: Determine the association between the Breast Cancer Surveillance Consortium v2 model (BCSC) risk score and advanced and non-advanced invasive breast cancer (IBC). ...
Dual-modality breast cancer screening compared to MRI or mammography alone among female Hodgkin lymphoma survivors who received chest radiotherapy [0.03%]
胸腺放疗的霍奇金淋巴瘤幸存女性的双模式乳腺癌筛查与单独进行MRI或乳房X线摄影的效果比较
Eline M J Lammers,Jeanne Beens-van Dijk,Annelies Nijdam et al.
Eline M J Lammers et al.
Purpose: Female Hodgkin lymphoma (HL) survivors treated with chest radiotherapy (RT) before the age of 40 years face increased breast cancer (BC) risk. Dutch guidelines recommend annual magnetic resonance imaging (MRI) an...
Comparative Study
Breast cancer research and treatment. 2026 Jan 28;215(3):64. DOI:10.1007/s10549-026-07898-5 2026
Second-line treatment strategy following CDK4/6 inhibitors for HR-positive and HER2-negative metastatic breast cancer patients: a multicentric, retrospective, observational study [0.03%]
CDK4/6抑制剂后续治疗HR阳性HER2阴性转移性乳腺癌患者策略的多中心回顾性观察研究
Olivia Lavigne,François Poumeaud,Thibaut Reverdy et al.
Olivia Lavigne et al.
Purpose: The standard first-line treatment for patients with hormone receptor-positive (HR +) human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer is cyclin-dependent kinase 4/6 (CDK4/6) inhi...
Observational Study
Breast cancer research and treatment. 2026 Jan 27;215(3):63. DOI:10.1007/s10549-025-07893-2 2026
Correction: Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling [0.03%]
关于索拉非尼对乳腺癌细胞能量代谢的影响及AMPK-mTORC1信号通路作用的更正论文：索拉非尼对乳腺癌细胞能量代谢的影响及AMPK-mTORC1信号通路的作用的更正
Claudia Fumarola,Cristina Caffarra,Silvia La Monica et al.
Claudia Fumarola et al.
Published Erratum
Breast cancer research and treatment. 2026 Jan 24;215(2):62. DOI:10.1007/s10549-025-07880-7 2026
Molecular and socioeconomic characteristics of inflammatory breast cancer in the Carolina Breast Cancer Study [0.03%]
北卡罗莱纳乳腺癌研究中的炎性乳腺癌的分子和社会经济特征
Qichen Wang,Sarah C Van Alsten,Xiaojia Ji et al.
Qichen Wang et al.
Purpose: Inflammatory breast cancer (IBC) has been hypothesized to represent a distinct molecular subtype. However, few IBC-specific gene expression patterns have been identified, and previous genomic studies of IBC have ...